Delpharm is investing € 28 million on a sterile line to manufacture prefilled syringes at its plant in Tours, France.   Delpharm began the project in April 2021 to create a new building dedicated to these dosage forms and will start manufacturing in 1Q23. With state-of-the-art equipment including isolator technology, Delpharm Tours will be able to produce between 25 and 30 million syringes per year.   The company will offer a wide range of formats and syringes and the manufacturing plant wil...